Works matching IS 1470269X AND DT 2015 AND VI 15 AND IP 3

Results: 13

Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 226, doi. 10.1038/tpj.2014.66

By:

Bohanes, P;
Yang, D;
Loupakis, F;
LaBonte, M J;
Gerger, A;
Ning, Y;
Lenz, C;
Lenz, F;
Wakatsuki, T;
Zhang, W;
Benhaim, L;
El-Khoueiry, A;
El-Khoueiry, R;
Lenz, H-J

Publication type:

Article

Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 248, doi. 10.1038/tpj.2014.63

By:

den Hoed, M A H;
Lopez-Lopez, E;
te Winkel, M L;
Tissing, W;
de Rooij, J D E;
Gutierrez-Camino, A;
Garcia-Orad, A;
den Boer, E;
Pieters, R;
Pluijm, S M F;
de Jonge, R;
van den Heuvel-Eibrink, M M

Publication type:

Article

Influence of single-nucleotide polymorphisms on deferasirox C<sub>trough</sub> levels and effectiveness.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 263, doi. 10.1038/tpj.2014.65

By:

Cusato, J;
Allegra, S;
Massano, D;
De Francia, S;
Piga, A;
D'Avolio, A

Publication type:

Article

Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 235, doi. 10.1038/tpj.2014.58

By:

Benhaim, L;
Zhang, W;
Wakatsuki, T;
Yang, D;
Gerger, A;
Bohanes, P;
Paez, D;
Loupakis, F;
LaBonte, M J;
Ning, Y;
El-Khoueiry, R;
Ladner, R;
Wilson, P;
Zhang, H;
Giamas, G;
Stebbing, J;
Lenz, H J

Publication type:

Article

Pharmacogenomic information in drug labels: European Medicines Agency perspective.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 201, doi. 10.1038/tpj.2014.86

By:

Ehmann, F;
Caneva, L;
Prasad, K;
Paulmichl, M;
Maliepaard, M;
Llerena, A;
Ingelman-Sundberg, M;
Papaluca-Amati, M

Publication type:

Article

Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 278, doi. 10.1038/tpj.2014.53

By:

Gamero-Villarroel, C;
González, L María;
Gordillo, I;
Carrillo, J Antonio;
García-Herráiz, A;
Flores, I;
Rodríguez-López, R;
Gervasini, G

Publication type:

Article

A polymorphism in HLA-G modifies statin benefit in asthma.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 272, doi. 10.1038/tpj.2014.55

By:

Naidoo, D;
Wu, A C;
Brilliant, M H;
Denny, J;
Ingram, C;
Kitchner, T E;
Linneman, J G;
McGeachie, M J;
Roden, D M;
Shaffer, C M;
Shah, A;
Weeke, P;
Weiss, S T;
Xu, H;
Medina, M W

Publication type:

Article

In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 241, doi. 10.1038/tpj.2014.60

By:

Gézsi, A;
Lautner-Csorba, O;
Erdélyi, D J;
Hullám, G;
Antal, P;
Semsei, Á F;
Kutszegi, N;
Hegyi, M;
Csordás, K;
Kovács, G;
Szalai, C

Publication type:

Article

Frequent intragenic rearrangements of DPYD in colorectal tumours.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 211, doi. 10.1038/tpj.2014.68

By:

van Kuilenburg, A B P;
Etienne-Grimaldi, M-C;
Mahamat, A;
Meijer, J;
Laurent-Puig, P;
Olschwang, S;
Gaub, M-P;
Hennekam, R C M;
Benchimol, D;
Houry, S;
Letoublon, C;
Gilly, F-N;
Pezet, D;
Andre, T;
Faucheron, J-L;
Abderrahim-Ferkoune, A;
Vijzelaar, R;
Pradere, B;
Milano, G

Publication type:

Article

High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 288, doi. 10.1038/tpj.2014.67

By:

Apellániz-Ruiz, M;
Inglada-Pérez, L;
Naranjo, M E G;
Sánchez, L;
Mancikova, V;
Currás-Freixes, M;
de Cubas, A A;
Comino-Méndez, I;
Triki, S;
Rebai, A;
Rasool, M;
Moya, G;
Grazina, M;
Opocher, G;
Cascón, A;
Taboada-Echalar, P;
Ingelman-Sundberg, M;
Carracedo, A;
Robledo, M;
Llerena, A

Publication type:

Article

The first steps towards the era of personalised vaccinology: predicting adverse reactions.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 284, doi. 10.1038/tpj.2014.57

By:

Pellegrino, P;
Falvella, F S;
Perrone, V;
Carnovale, C;
Brusadelli, T;
Pozzi, M;
Antoniazzi, S;
Cheli, S;
Perrotta, C;
Clementi, E;
Radice, S

Publication type:

Article

Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 255, doi. 10.1038/tpj.2014.59

By:

Chidambaran, V;
Mavi, J;
Esslinger, H;
Pilipenko, V;
Martin, L J;
Zhang, K;
Sadhasivam, S

Publication type:

Article

MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin.

Published in:

Pharmacogenomics Journal, 2015, v. 15, n. 3, p. 219, doi. 10.1038/tpj.2014.64

By:

Cecchin, E;
Perrone, G;
Nobili, S;
Polesel, J;
De Mattia, E;
Zanusso, C;
Petreni, P;
Lonardi, S;
Pella, N;
D'Andrea, M;
Errante, D;
Rizzolio, F;
Mazzei, T;
Landini, I;
Mini, E;
Toffoli, G

Publication type:

Article